Market Overview:
The global cabazitaxel API market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising demand for cabazitaxel API drugs, and technological advancements in the pharmaceutical industry. Based on type, the global cabazitaxel API market is segmented into purity ≥98%.
Product Definition:
Cabazitaxel API is a Taxane that is used in the treatment of prostate cancer. It helps to prevent the cancer cells from dividing and growing.
Purity≥98%:
Cabazitaxel is a chemotherapy drug used in the treatment of prostate cancer. It works by killing rapidly dividing cells, mainly in the prostate gland. Prostate cancer is one of the most common cancers in men aged 45 years and above. According to WHO, it was estimated that around 1 million cases were diagnosed each year globally as of 2012 with an expected increase due to aging and obesity.
Purity
Cabazitaxel is a chemotherapy drug used for the treatment of breast cancer. It is an analogues of thio-caboxylic acid which has shown efficacy in preclinical and clinical trials with higher dose levels (75mg/m2) than those used in current commercial products.
Application Insights:
Cabazitaxel injections were the most prominent application segment in 2017 and accounted for a revenue share of over 80%. The increasing use of cabazitaxel as a chemotherapeutic agent in the treatment of various cancers, such as breast cancer, lung cancer, liver cancer and others is anticipated to boost market growth. In addition, its ability to inhibit angiogenesis coupled with its low toxicity makes it suitable for treating several cancers.
The other applications include cabozantinib (Cometriq), palbociclib (Ibrance), bezlotoxumomab (ZELTRA) and calreticulin inhibitor (Calquence). Cabozantinib is an oral kinase inhibitor that targets B-Raf which has high potential in the treatment of non-small cell lung carcinoma. However, only one drug candidate - Cometriq has been approved by U.
Regional Analysis:
North America dominated the global cabazitaxel API market in 2017. The presence of major players, favorable government initiatives and increasing R&D activities are some of the factors responsible for its large share. For instance, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., a biotechnology company that is engaged in developing novel immunotherapies based on tumor-specific antigens has collaborated with CELGENE CORPORATION to develop a new generation of cancer vaccines under project code IMMU-CTLA4 collaboration (IMMU stands for Immunotherapy Cancer Vaccine).
Growth Factors:
- Increasing incidence of prostate cancer: The incidence of prostate cancer is increasing globally. This will drive the demand for cabazitaxel API in the coming years.
- Growing awareness about advanced treatment options: There is a growing awareness among patients and healthcare professionals about the benefits of using cabazitaxel API for treating advanced prostate cancer. This will help to boost the demand for this drug in the coming years.
- Rising number of clinical studies on cabazitaxel API: A large number of clinical studies are being conducted on cabazitaxel API across the world, which is helping to create awareness about its potential benefits in treating prostate cancer patients who have failed previous treatments. This will help to fuel its demand in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cabazitaxel API Market Research Report
By Type
Purity≥98%, Purity<98%
By Application
Cabazitaxel Injections, Others
By Companies
Dr. Reddy's Laboratories, Teva API, VShilpa Medicare Limitedbshilpa, Indena, Synthland, Suzhou Ryway Biotech, Mac-Chem Products (India) Pvt.Ltd, Shenzhen Haorui Industrial Dev. Co., Ltd, Hanways Chempharm Co., Limited
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Cabazitaxel API Market Report Segments:
The global Cabazitaxel API market is segmented on the basis of:
Types
Purity≥98%, Purity<98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cabazitaxel Injections, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dr. Reddy's Laboratories
- Teva API
- VShilpa Medicare Limitedbshilpa
- Indena
- Synthland
- Suzhou Ryway Biotech
- Mac-Chem Products (India) Pvt.Ltd
- Shenzhen Haorui Industrial Dev. Co., Ltd
- Hanways Chempharm Co., Limited
Highlights of The Cabazitaxel API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity≥98%
- Purity<98%
- By Application:
- Cabazitaxel Injections
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cabazitaxel API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cabazitaxel API (cabazitaxel injection) is a medication used to treat cancer. It is a chemotherapy drug that works by killing cancer cells.
Some of the key players operating in the cabazitaxel api market are Dr. Reddy's Laboratories, Teva API, VShilpa Medicare Limitedbshilpa, Indena, Synthland, Suzhou Ryway Biotech, Mac-Chem Products (India) Pvt.Ltd, Shenzhen Haorui Industrial Dev. Co., Ltd, Hanways Chempharm Co., Limited.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cabazitaxel API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cabazitaxel API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cabazitaxel API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cabazitaxel API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cabazitaxel API Market Size & Forecast, 2020-2028
4.5.1 Cabazitaxel API Market Size and Y-o-Y Growth
4.5.2 Cabazitaxel API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity≥98%
5.2.2 Purity<98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cabazitaxel Injections
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cabazitaxel API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cabazitaxel API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity≥98%
9.6.2 Purity<98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cabazitaxel Injections
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity≥98%
10.6.2 Purity<98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cabazitaxel Injections
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity≥98%
11.6.2 Purity<98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cabazitaxel Injections
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity≥98%
12.6.2 Purity<98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cabazitaxel Injections
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity≥98%
13.6.2 Purity<98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cabazitaxel Injections
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cabazitaxel API Market: Competitive Dashboard
14.2 Global Cabazitaxel API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Dr. Reddy's Laboratories
14.3.2 Teva API
14.3.3 VShilpa Medicare Limitedbshilpa
14.3.4 Indena
14.3.5 Synthland
14.3.6 Suzhou Ryway Biotech
14.3.7 Mac-Chem Products (India) Pvt.Ltd
14.3.8 Shenzhen Haorui Industrial Dev. Co., Ltd
14.3.9 Hanways Chempharm Co., Limited
